Patient Outcomes Following Total Joint Replacement Surgery: A Comparison of Hospitals and Ambulatory Surgery Centers
Patient Outcomes Following Total Joint Replacement Surgery: A Comparison of Hospitals and Ambulatory Surgery Centers
批准号:
9896744
负责人:
Kathleen Carey
金额:
$8.25万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2020-12-31
关键词:
Ambulatory Surgical ProceduresAreaBusinessesCaringCategoriesCessation of lifeComplexDataDeep Vein ThrombosisDiagnosis-Related GroupsDislocationsEnrollmentExpenditureFrightHealthHealth systemHospitalsInpatientsInterventionMeasuresMedicareModelingOperative Surgical ProceduresOutcomeOutpatientsPatient-Focused OutcomesPatientsPhysiciansPoliciesPopulationPostoperative ComplicationsPrivatizationProceduresProsthesisProviderPulmonary EmbolismReplacement ArthroplastyResearchResourcesRiskRisk AdjustmentSamplingServicesSiteSurgical Wound InfectionTechniquesTestingTimebasebeneficiarycare deliverycare episodedesignhigh riskhip replacement arthroplastyhospital readmissionknee replacement arthroplastymedical specialtiesmigrationolder patientoutpatient facilitypatient engagementpatient safetypaymentrelative cost
中文摘要
项目总结/摘要
CMS最近开始支付全膝关节置换手术(关节成形术; TKA),
医院门诊部(HOPD),并正在考虑报销HOPD全髋关节
关节成形术(THA)。许多观察家预计,医疗保险支付TKA和THA在门诊
手术中心(ASCs)。目前,全关节置换术正在进行,
在HOPD和越来越多的ASC中,商业保险患者。但尽管
ASC的医生所有者声称门诊全关节置换术是适当的,
对于大部分候选人来说是安全的,迄今为止的证据是基于一组有限的研究,
在HOPD中接受治疗的患者样本非常少。随着ASC稳步扩大其
一些专家担心,他们忽视了高风险,
健康问题然而,有可能在较少依赖的情况下实现类似的结果
传统卫生系统资源。在美国,大多数关节置换接受者
是医疗保险受益人,该人群中门诊TKA的结局数据将不会
一段时间内可用。在此期间,我们建议比较TKA和THA的结局,
使用大样本的商业-
有保险的病人我们将在一个研究中识别接受TKA或THA的近老年患者,
2014-2019年期间住院或门诊ASC设置,并连续入组
手术后90天。我们将从住院患者、HOPD患者中选择匹配的患者样本,
和ASC设置,使用倾向评分技术,与从
HHS分层条件类别风险调整模型,
ACA适用于商业保险人群。我们将查明
相关的30天和90天再入院,以及翻修手术后90天内的病例,手术
部位感染、深静脉血栓形成、肺栓塞和脱位/松动/断裂
的假肢。我们将使用统计技术来测试各研究中心之间的差异。最后我们将
衡量护理阶段的相对成本,包括护理期间发生的相关支出。
90-住院后第1天或ASC就诊。这个项目将启发CMS的潜力
进一步过渡到门诊手术的健康后果。对于供应商,它将确定
潜在的患者安全漏洞领域和干预目标。最后,它将促进
通过告知门诊联合的“灰色区域”候选人,
在决定在哪里做手术时做出更明智的决定。
英文摘要
Project Summary/Abstract
CMS recently began paying for total knee replacement surgery (arthroplasty; TKA) performed in
hospital outpatient departments (HOPDs) and is considering reimbursing for HOPD total hip
arthroplasty (THA). Many observers expect Medicare payment for TKA and THA in ambulatory
surgery centers (ASCs) to follow. Currently, total joint replacements are being performed on
commercially insured patients in HOPDs and in a growing number of ASCs. However, despite
claims by physician-owners of ASCs that outpatient total joint replacement is appropriate and
safe for a large portion of candidates, evidence to date is based on a limited set of studies using
very small samples of patients treated in HOPDs. As ASCs have steadily expanded their
business and taken on increasingly complex surgeries, some experts fear they overlook high-risk
health problems. Yet it is possible that comparable outcomes can be achieved with less reliance
on traditional health system resources. The majority of joint replacement recipients in the U.S.
are Medicare beneficiaries, and outcomes data on outpatient TKA in this population will not be
available for some time. In the interim, we propose to compare TKA and THA outcomes and
payments across inpatient, HOPD, and ASC settings using a large sample of commercially-
insured patients. We will identify near elderly patients who underwent TKA or THA in an
inpatient or outpatient ASC setting during 2014-2019 and who were continuously enrolled for
90 days following surgery. We will select matched samples of patients across inpatient, HOPD
and ASC settings using propensity score techniques, matching with risk scores generated from
the HHS Hierarchical Condition Categories risk adjustment model which was designed under
the ACA for application to the commercially-insured population. We will identify cases of
related 30-day and 90-day readmission, and cases within 90-days of revision surgery, surgical
site infection, deep-vein thrombosis, pulmonary embolism, and dislocation/loosening/breakage
of prosthesis. We will test differences across sites using statistical techniques. Finally, we will
measure the relative cost of episodes of care including related expenditures incurred during the
90-day post-inpatient stay or ASC encounter. This project will enlighten CMS on potential
health consequences of further transitions to outpatient surgery. For providers, it will identify
areas of potential patient safety lapses, and targets for interventions. Finally, it will facilitate
patient engagement in their care by informing “gray area” candidates for outpatient joint
replacement in making wiser decisions about where to undergo surgery.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Behavioral Health Integration in Community Health Centers and Hospital Emergency Department Utilization
-
批准号:10364901
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2022
-
负责人:Kathleen Carey
-
依托单位:
Safety-Net Hospitals Under Mandatory Bundled Payment
-
批准号:10296964
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2021
-
负责人:Kathleen Carey
-
依托单位:
Profiling Improvement under the Hospital Readmissions Reduction Program
-
批准号:9181045
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2016
-
负责人:Kathleen Carey
-
依托单位:
The Impact of CMS Public Reports of Hospital Charge Data
-
批准号:9244429
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2016
-
负责人:Kathleen Carey
-
依托单位:
An Investigation into Hospital Lengths of Stay and Costly Readmissions
-
批准号:8228864
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2011
-
负责人:Kathleen Carey
-
依托单位:
Inpatient Safety and Costs in U.S. Hospitals
-
批准号:7589398
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2009
-
负责人:Kathleen Carey
-
依托单位:
The Effects of Single Specialty Hospital Entry on Hospital Market Competition
-
批准号:7215409
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2006
-
负责人:Kathleen Carey
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: